Ionis Pharmaceuticals | IONS - Assets


Ionis Pharmaceuticals reported $2.91B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Agios Pharmaceuticals USD 1.06B 44.38M Sep/2026
Alnylam Pharmaceuticals USD 7.99B 2.44B Sep/2026
Arrowhead Research USD 2.11B 156.25M Jun/2026
Astellas Pharma JPY 3.53T 164.74B Sep/2026
BioCryst Pharmaceuticals USD 591.07M 33.22M Sep/2026
BioMarin Pharmaceutical USD 11.57B 154.21M Sep/2026
Celltrion KRW 779.18B 10.37B Jun/2026
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Divis Laboratories Ltd INR 219.64B 19.31B Sep/2026
Exelixis USD 2.51B 19.26M Sep/2026
Halozyme Therapeutics USD 3.47B 895.94M Sep/2026
Ionis Pharmaceuticals USD 2.91B 81.91M Sep/2026
Kangmei Pharma CNY 13.07B 239.31M Jun/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 63.57M 2.83M Dec/2025
Moderna USD 13.47B 2.51B Sep/2026
Nektar Therapeutics USD 763.27M 482.86M Mar/2026
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
Neurocrine Biosciences USD 5.63B 268.3M Sep/2026
Novartis USD 117.15B 4.88B Sep/2026
Omeros USD 200.57M 34.59M Jun/2025
OPKO Health USD 1.83B 27.34M Jun/2026
Organigram Holdings CAD 820.26M 298.95M Jun/2026
Ovoca Bio EUR 2.07M 414K Dec/2025
Pfizer USD 204.54B 3.41B Sep/2026
Pharma Mar EUR 408.4M 14.8M Sep/2026
PTC Therapeutics USD 3.21B 42.76M Sep/2026
Qiagen NV USD 5.89B 107.14M Jun/2026
Regeneron Pharmaceuticals USD 44.41B 2.67B Sep/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sarepta Therapeutics USD 3.17B 22.45M Sep/2026
Sartorius EUR 9.67B 70.9M Sep/2026
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Tilray USD 2.1B 15.95M Sep/2025
Ultragenyx Pharmaceutical USD 1.19B 77M Sep/2026
Vertex Pharmaceuticals USD 32.74B 5.31B Sep/2026
Zealand Pharma A/S 15.3B 647.8M Mar/2026
Zz Pientze Pharmaceu CNY 17.71B 799.05M Sep/2026